HEALTH SERVICE EXECUTIVE

Their core work

Ireland's national public health service (HSE) contributes real-world healthcare system expertise, patient data, and clinical infrastructure to European research consortia. Their participation spans population health monitoring, vaccine effectiveness surveillance, emergency medical response coordination, and cybersecurity for hospital networks. HSE acts as a living laboratory — providing access to a full national health system's operations, data, and frontline professionals for testing and validating research outputs in actual care settings.

What they specialise in

How they've shifted over time

In the earlier period (2015–2018), HSE focused on environmental health exposure (human biomonitoring, chemical mixtures, endocrine disruptors via HBM4EU) and crisis preparedness infrastructure (IN-PREP's mixed reality training and command-control systems). From 2019 onward, the focus shifted decisively toward direct healthcare delivery challenges — digital screening tools, healthcare cybersecurity, COVID-19 surveillance, and practitioner training networks. This arc reflects a move from contributing to broad monitoring frameworks toward addressing operational healthcare system needs like security, digital diagnostics, and pandemic response.

HSE is moving toward digitally-enabled population health tools and healthcare system security, making them a strong partner for projects needing real-world health system deployment and validation.

How they like to work

HSE exclusively joins consortia as a participant or third party — they have never coordinated an H2020 project. With 406 unique partners across 43 countries, they operate as a wide-network contributor rather than a repeat-partner hub. This pattern is typical of a national health service that provides domain access and validation capacity rather than driving research agendas, making them a reliable but non-leading consortium member.

HSE has collaborated with 406 unique partners across 43 countries, giving them one of the broadest networks among Irish public bodies in H2020. Their connections span Western Europe heavily but extend globally through large-scale health monitoring and rare disease consortia.

What sets them apart

HSE's distinctive value is that it IS a national health system — not a university studying one, but the operational entity delivering care to 5 million people. This gives consortia direct access to clinical workflows, patient populations, national health data, and frontline staff for piloting and validation. Few H2020 participants can offer deployment-ready health infrastructure at country scale.

Highlights from their portfolio

• I-MOVE-plus
  Largest HSE project by funding (€325K), part of a pan-European vaccine effectiveness monitoring platform that proved its value during COVID-19.
• PANACEA
  Unusual intersection of healthcare and cybersecurity — HSE brought real hospital infrastructure context to cyber threat assessment and privacy-by-design for health systems.
• AFFECT-EU
  Represents HSE's emerging digital health direction — population-scale atrial fibrillation screening using biomarkers and digital tools for stroke prevention.